XML 58 R51.htm IDEA: XBRL DOCUMENT v3.26.1
Revenue Interest Purchase Agreement - Additional Information (Details) - Purchase Agreement - OrbiMed - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 22, 2026
Sep. 12, 2022
Jun. 30, 2026
Jun. 30, 2026
Dec. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Upfront payment received   $ 125,000,000      
Revenue interest payment term   45 days      
Proceeds from notes offering to repurchase revenues $ 156,900,000        
Loss on revenue interest liability extinguishment     $ 23,700,000 $ 23,733,000  
Amortization of purchase agreement obligation       0  
Debt issuance costs     $ 600,000 600,000  
Revenue interest payable       $ 0 $ 3,600,000